New national survey study aims to improve equity in Canadian cancer clinical trials

A new Canadian Cancer Trials Group (CCTG) survey study, SC32S, has opened across Canada to collect sociodemographic data from cancer clinical trial participants and assess whether asking questions about this information feels appropriate to patients. The patient survey will ask CCTG trial participants about different parts of everyday life that can affect patient health and experience with cancer care.

BC Cancer investigators participate in CCTG VISION Leadership Program

Three BC Cancer clinical investigators are participating in the Canadian Cancer Trials Group (CCTG) VISION – Investigator Leadership Training Program, a new education and mentorship initiative focused on developing leadership skills among current and emerging clinical trialists.

Drs. Leah Lambert, Jonathan Loree and Lucia Nappi are part of the inaugural VISION cohort.

Back to top